News summary

Outcome-specific value of longitudinal clinical information and model complexity for dynamic prediction of type 2 diabetes-related outcomes: a pooled landmarking study

Source: Frontiers - Health • Published: 02 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Type 2 diabetes risk prediction methods are examined, comparing use of longitudinal versus current clinical data and model complexity in annual landmarking.

Outcome-specific value of longitudinal clinical information and model complexity for dynamic prediction of type 2 diabetes-related outcomes: a pooled landmarking study
Key Takeaways
  • The cohort included 646 type 2 diabetes patients with complete annual records from baseline through year three.
  • Four progressively expanded feature sets were compared using elastic-net logistic regression and LightGBM for landmark predictions.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.